ReNeuron is a UK-based stem cell research company, whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem cell therapies targeting areas of poorly met medical need, including peripheral arterial disease, stroke, and retinal diseases.
Above text from Wikipedia is available under the CC-BY-SA license.
- Biotechnology companies
- 1. Wikipedia. ReNeuron
- 2. Department for Business, Innovation and Skills. Ministerial meetings with outside interests, 1 Jan - 31 Mar 2011
This profile was compiled by Who's Lobbying and is about ReNeuron.
This page is not endorsed by or affiliated with ReNeuron.
Problem with this information?
Please let us know by emailing: